SCHEMBL24569263

SCHEMBL24569263

O=C1c2ccccc2C2(c3ccccc31)c1ccccc1N1c3ccccc3Sc3cccc2c31

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOX1 Q9Y5S8 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
BCHE P06276 5/20 0.34
MAOA P21397 1/20 0.33
HDAC6 Q9UBN7 2/20 0.33
ACHE P22303 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
HDAC3 O15379 1/20 0.32
TUBB4A P04350 1/20 0.32
TUBB P07437 1/20 0.32
TUBA3C P0DPH7 1/20 0.32
HDAC4 P56524 1/20 0.32
TUBA1B P68363 1/20 0.32
TUBA4A P68366 1/20 0.32
TUBB4B P68371 1/20 0.32
TUBB3 Q13509 1/20 0.32
HDAC1 Q13547 1/20 0.32
TUBB2A Q13885 1/20 0.32
TUBB8 Q3ZCM7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24569837 0.88 BCHE (0.34) NOX1MEN1KMT2ABCHEMAOA
SCHEMBL24608666 0.87 BCHE (0.34) MEN1KMT2ABCHEMAOAL3MBTL1
SCHEMBL24608878 0.86 NPC1 (0.39) NOX1MEN1KMT2ABCHEL3MBTL1
SCHEMBL24608664 0.85 KMT2A (0.37) MEN1KMT2ABCHEL3MBTL1ALDH1A1
SCHEMBL24608705 0.85 LMNA (0.37) ACHE
SCHEMBL24608715 0.85 NPSR1 (0.45) NOX1MEN1KMT2AHDAC6HDAC3
SCHEMBL24608698 0.85 ELANE (0.35) NOX1MEN1KMT2ABCHEALDH1A1
SCHEMBL24608699 0.85 BCHE (0.33) MEN1KMT2ABCHEL3MBTL1
SCHEMBL24608706 0.85 BCHE (0.42) MEN1KMT2ABCHEHDAC6ACHE
SCHEMBL24608701 0.85 NOX1 (0.34) NOX1BCHEMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917912-B2 Organic compound, organic light-emitting element, display apparatus, photoelectric conversion apparatus, electronic apparatus, illumination apparatus, moving object, and exposure light source CANON KABUSHIKI KAISHA (JP) 2024-02-27 US disclosed
US-11917912-B2 Organic compound, organic light-emitting element, display apparatus, photoelectric conversion apparatus, electronic apparatus, illumination apparatus, moving object, and exposure light source CANON KABUSHIKI KAISHA (JP) 2024-02-27 US disclosed
US-20220216423-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY APPARATUS, PHOTOELECTRIC CONVERSION APPARATUS, ELECTRONIC APPARATUS, ILLUMINATION APPARATUS, MOVING OBJECT, AND EXPOSURE LIGHT SOURCE CANON KABUSHIKI KAISHA (JP) 2022-07-07 US disclosed
EP-4019504-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY APPARATUS, PHOTOELECTRIC CONVERSION APPARATUS, ELECTRONIC APPARATUS, ILLUMINATION APPARATUS, MOVING OBJECT, AND EXPOSURE LIGHT SOURCE CANON KABUSHIKI KAISHA (JP) 2022-06-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917912-B2 Organic compound, organic light-emitting element, display apparatus, photoelectric conversion apparatus, electronic apparatus, illumination apparatus, moving object, and exposure light source AOX1, SOD1, L1CAM NOX1 87/4885MEN1 2311/4885KMT2A 2215/4885
US-20220216423-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY APPARATUS, PHOTOELECTRIC CONVERSION APPARATUS, ELECTRONIC APPARATUS, ILLUMINATION APPARATUS, MOVING OBJECT, AND EXPOSURE LIGHT SOURCE AOX1, SOD1, L1CAM NOX1 87/4885MEN1 2311/4885KMT2A 2215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.